HCV-Infected Liver Transplant Patients Benefit from DAA Use,

Results from the retrospective cohort study indicated viral eradication with DAAs after liver transplantation improved liver function and patient survival after a long-term follow-up, even in cirrhotic patients.

Related Keywords

Italy , Martina Gambato , World Health Organization , Department Of Oncological , Gastroenterological Surgical Sciences , Interquartile Range , Thcv , Hepatitis C , Fibrosis , Transplant , Direct Acting Antiviral , Daa ,